Cover of: Pricing of drugs codeveloped by federal laboratories and private companies | United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Read Online
Share

Pricing of drugs codeveloped by federal laboratories and private companies hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993. by United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology.

  • 375 Want to read
  • ·
  • 34 Currently reading

Published by U.S. G.P.O., For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office in Washington .
Written in English

Subjects:

Places:

  • United States.,
  • United States

Subjects:

  • Drugs -- Prices -- United States.,
  • Orphan drugs -- Prices -- United States.,
  • Drugs -- Research -- United States -- Finance.,
  • Pharmaceutical industry -- United States.

Book details:

Classifications
LC ClassificationsKF27 .S675 1993c
The Physical Object
Paginationiv, 237 p. :
Number of Pages237
ID Numbers
Open LibraryOL1147447M
ISBN 100160407648
LC Control Number94119866
OCLC/WorldCa28152224

Download Pricing of drugs codeveloped by federal laboratories and private companies

PDF EPUB FB2 MOBI RTF

Full text of "Pricing of drugs codeveloped by federal laboratories and private companies: hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, Janu " See other formats. An Analysis of Drug Pricing, Not Drug Spending Drug pricing, as examined in this paper, differs from drug spending in several ways. First, the prices paid to manufacturers for single-source brand-name pre-scription drugs under selected federal programs do not reflect the final cost of dispensing the drug File Size: KB. The Medicaid Drug Rebate Program requires pharmaceutical companies to enter into and have in effect a national rebate agreement with the Secretary of Health and Human Services in order for Medicaid payments to be available for the pharmaceutical company's covered drugs. Companies with such rebate agreements are required to submit certain drug. A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. Security Boulevard, Baltimore, MD

  In the United States, the price of prescription drugs is relatively unregulated, enabling pharmaceutical companies to increase their drug prices beyond inflation rates .   The VA Drug Pricing database contains the current prices for pharmaceuticals purchased by the federal government. These listed prices are based on the Federal Supply Schedule (FSS). This database is mandated by Public Law , the Veterans Health Care Act of , which sets the maximum amount that a drug may be bought for by the Veterans. The Federal Supply Schedule (FSS) Service awards multi-year, multiple award federal contracts that are available for use by any eligible Federal Government agency. It satisfies all Federal contract laws and regulations. Pricing is negotiated based on how vendors do business with their commercial customers.   Among the drugs that were developed with some public funding and went on to be huge earners for private companies are the HIV drug AZT and .

Germany allows drug companies to set their own initial prices but may set maximum prices for patent-protected drugs, use references prices for drugs in a therapeutic class, require initial use of alternate treatments or deny reimbursement of “inefficient drugs”. 15 In the United Kingdom, the National Institute for Health and Care Excellence. To improve prescription drug price transparency, the TruthinRx campaign is focusing on three major market players who significantly impact drug prices: Pharmaceutical companies. Pharmaceutical companies make and sell drugs, but don’t explain pricing or why costs can greatly exceed research-and-development (R&D) expenses. Wholesale Acquisition Cost (WAC) as published by FDB represents the manufacturer’s (for purposes of this Drug Pricing Policy, the term “manufacturer” includes manufacturers, repackagers, private labelers and other suppliers) published catalog or list price for a drug product to wholesalers as reported to FDB by the manufacturer. WAC does. For many widely used generic drugs, state insurance plans are collectively paying millions of dollars in fees to private companies. CVS is run from Woonsocket, Rhode Island, and is best known for.